Remedy Plan, Inc.

Pharmaceutical company · Gaithersburg, Maryland, United States

Remedy Plan, Inc. is a pharmaceutical company headquartered in Gaithersburg, Maryland, United States. It has received 1 NIH small-business research grant, $1.2 million in total. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Remedy Plan at a glance

Typepharmaceutical company
HeadquartersGaithersburg, Maryland, United States
SEC CIK1757460

What does Remedy Plan do?

US government research funding

1 NIH small-business research grant, $1.2 million in total. NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $19.1 million sold (2023).

Frequently asked questions about Remedy Plan

Where is Remedy Plan headquartered?

Remedy Plan, Inc. is headquartered in Gaithersburg, Maryland, United States.

What does Remedy Plan do?

Remedy Plan, Inc. is a pharmaceutical company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences